Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Events & presentations

09 Jul 2015 - 12 Jul 2015

ISOPT, July 9-12, 2015, Berlin, Germany

21 Jun 2015 - 24 Jun 2015

EUNOS, 21-24 June, 2015, Ljubljana, Slovenia

15 Jun 2015 - 17 Jun 2015

BIO, June 15-17, 2015, Philadelphia (PA)

05 Jun 2015 - 07 Jun 2015

Mitocon, June 5-7, 2015, Bologna, Italy

03 May 2015 - 07 May 2015

ARVO, May 3-7, 2015, Denver, Colorado

22 Apr 2015 - 24 Apr 2015

April 22-24, 2015: GenSight will present at the World Orphan Drug Congress

12 Mar 2015

March 12, 2015: GenSight participated at the 5th Annual Advanced Therapies Summit,

09 Mar 2015 - 11 Mar 2015

March 9-11, 2015: GenSight attended BioEurope Spring, Paris.

21 Feb 2015 - 26 Feb 2015

February 21-26, 2015:  GenSight attended NANOS

12 Jan 2015 - 16 Jan 2015

January 12-16, 2015: GenSight presented at the 33rd Annual J.P. Morgan Healthcare Conference, San Francisco (CA),

  • View previous 9 articles
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page